Barclays Keeps Their Sell Rating on Wizz Air Holdings (WIZZ)
Barclays analyst Andrew Lobbenberg maintained a Sell rating on Wizz Air Holdings (WIZZ – Research Report) today and set a price target of £9.00. The company's shares closed last Friday at p1,174.00.
Confident Investing Starts Here:
Lobbenberg covers the Industrials sector, focusing on stocks such as Deutsche Lufthansa, International Consolidated Airlines, and Aegean Airlines. According to TipRanks, Lobbenberg has an average return of 2.0% and a 50.84% success rate on recommended stocks.
In addition to Barclays, Wizz Air Holdings also received a Sell from Jefferies's Jaina Mistry in a report issued on June 5. However, on June 6, J.P. Morgan maintained a Hold rating on Wizz Air Holdings (LSE: WIZZ).
The company has a one-year high of p2,548.00 and a one-year low of p1,135.00. Currently, Wizz Air Holdings has an average volume of 617.2K.
Based on the recent corporate insider activity of 24 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of WIZZ in relation to earlier this year.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Barclays Rises 32.3% YTD: Is it the Right Time to Buy the Stock?
Year to date, shares of Barclays PLC BCS have risen 32.3%. The stock has outperformed the S&P 500 index, the Zacks Finance sector, and the industry. Meanwhile, it has underperformed its close peer, Deutsche Bank DB, while outperforming HSBC Holdings PLC HSBC. Year-to-Date Price Performance Image Source: Zacks Investment Research However, lingering uncertainty around tariff policies continues to pose risks. Given this backdrop, let's assess whether Barclays stock is a lucrative bet or not. Restructuring Efforts to Boost Profitability: Barclays has been taking steps to divest unprofitable/less profitable operations and save expenses through business streamlining, while deploying capital into higher revenue-generating February 2025, Barclays sold its consumer finance business in Germany. Last year, the company transformed its operating divisions and divested its Italian mortgage portfolio and $1.1 billion in credit card these efforts, Barclays recorded gross savings of £1 billion in 2024 and £150 million in the first quarter of 2025. The company aims to achieve gross efficiency savings of £0.5 billion this year. By 2026, management expects total gross efficiency savings to be £2 billion and the cost-to-income ratio to be in the high 50s. Its first-quarter 2025 cost-to-income ratio was 57%.The company is investing these savings in high-growth businesses and markets. This April, Barclays entered into a collaboration with Brookfield Asset Management Ltd. to reshape its payment acceptance business with plans to inject roughly £400 million. In March, the bank had announced a capital injection of more than INR2,300 crore (£210 million) into its India operations, following an injection of almost INR3,000 crore (£300 million) in 2021. Last year, the company acquired Tesco's retail banking business, which complements its existing business. In 2023, Barclays acquired Kensington Mortgage, which bolstered its mortgage redeployment of capital into higher-growth businesses and markets through improving efficiency is a multifaceted approach to boosting profitability. Barclays remains committed to this approach, which is likely to help improve profitability over Capital Distributions: As of March 31, 2025, Barclays' liquidity coverage ratio and net stable funding ratio were 175.3% and 136.2%, respectively, well above the regulatory requirements. This indicates a solid liquidity and funding profile. Thus, a solid balance sheet position supports its enhanced capital company has been paying dividends regularly and plans to keep the total dividend payout stable at the 2023 level, with progressive dividend plans to return at least £10 billion of capital to shareholders between 2024 and 2026 through dividends and share buybacks, with a continued preference for bank has increased dividends six times in the past five years with an annualized growth rate of 45.04%. It has a dividend payout ratio of 28%. Barclays Dividend Yield Image Source: Zacks Investment Research Over the past two months, the Zacks Consensus Estimate for 2025 earnings per share has been revised 6.2% and 3% upward to $2.23 and $2.73, respectively. Estimate Revision Trend Image Source: Zacks Investment Research The Zacks Consensus Estimate for Barclays' 2025 and 2026 earnings implies year-over-year growth of 21.2% and 22.6%, respectively. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) BCS stock is currently trading at a forward 12-month price/earnings (P/E) of 7.17X. This is below the industry's 9.4X, reflecting an attractive valuation. Price-to-Earnings F12M Image Source: Zacks Investment Research On the other hand, Deutsche Bank and HSBC have a forward P/E of 8.31X and 8.64X, respectively. This reflects that Barclays is trading at a discount compared to its peers. Entering 2025, a major rebound in mergers and acquisitions (M&As) was expected, with deal-making activities likely to grow in the mid-20s. This optimism stemmed from pent-up demand, stabilizing or declining interest rates, tightening credit spreads, and strong public market valuations. Also, the Trump administration was perceived as business-friendly, with an expected removal of stringent oversight that could mark the end of the prolonged regulatory of these has transpired till now. Deal-making activities have been muted as ambiguity over the tariff and ensuing trade war has resulted in extreme market volatility. These developments have led to economic uncertainty. Against such a backdrop, companies are rethinking their M&A plans despite stabilizing rates and having significant investible management expects investment banking risk-weighted assets (RWAs) to be 50% of the Group RWAs in 2026. Further, the delay in the M&A rebound will impact the IB business of other global banks, including HSBC and Deutsche Bank, impacting revenue growth to some extent. Barclays' restructuring efforts to boost efficiency and redeployment of capital to higher revenue-generating businesses are likely to help the company's financials. Further, a solid liquidity profile enables sustainable capital distributions. Bullish analyst sentiments and attractive valuations are other the bank's core operating performance remains a concern. Net interest income (NII) and net fee, commission, and other income have been witnessing a volatile trend over the last several quarters owing to a tough operating backdrop. Though NII and net fee, commission, and other income rose in 2024 and in the first quarter of 2025, in light of structural hedges and Tesco bank buyout, the uncertainty about the performance of the capital markets might weigh on the company's top line, which makes us apprehensive about its growth prospects. Further, the likelihood of a significant IB rebound this year remains low amid concerns regarding tariff policies, making BCS stock a cautious shareholders may benefit from holding for strong long-term returns, while potential investors should wait for greater macroeconomic clarity before taking a currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Barclays PLC (BCS) : Free Stock Analysis Report Deutsche Bank Aktiengesellschaft (DB) : Free Stock Analysis Report HSBC Holdings plc (HSBC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Discover UK Penny Stocks To Watch In June 2025
The UK market has faced challenges recently, with the FTSE 100 index closing lower due to weak trade data from China, highlighting concerns about global economic recovery. Despite these broader market difficulties, certain investment opportunities remain attractive. Penny stocks, while often considered a relic of past trading days, still offer potential for growth when they are backed by strong financials and solid fundamentals. In this article, we explore several penny stocks that stand out as promising candidates for investors seeking hidden value in the UK market. Name Share Price Market Cap Financial Health Rating Foresight Group Holdings (LSE:FSG) £4.035 £453.9M ★★★★★★ Warpaint London (AIM:W7L) £4.70 £379.7M ★★★★★★ Cairn Homes (LSE:CRN) £1.876 £1.17B ★★★★★☆ Ultimate Products (LSE:ULTP) £0.756 £63.63M ★★★★★☆ Van Elle Holdings (AIM:VANL) £0.385 £41.66M ★★★★★★ Polar Capital Holdings (AIM:POLR) £4.525 £436.27M ★★★★★★ LSL Property Services (LSE:LSL) £2.99 £308.82M ★★★★★☆ Begbies Traynor Group (AIM:BEG) £1.095 £174.69M ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.86 £11.84M ★★★★★★ Braemar (LSE:BMS) £2.31 £72.24M ★★★★★★ Click here to see the full list of 407 stocks from our UK Penny Stocks screener. We'll examine a selection from our screener results. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Afentra plc is an upstream oil and gas company focused on operations in Africa, with a market cap of £107.65 million. Operations: The company's revenue is derived from its Oil & Gas - Exploration & Production segment, totaling $180.86 million. Market Cap: £107.65M Afentra plc, an upstream oil and gas company, has shown notable financial improvements with revenues reaching US$180.86 million for the year ending December 2024, a substantial increase from the previous year's US$26.39 million. The company transitioned to profitability with a net income of US$52.35 million compared to a prior net loss. Afentra's strong cash position exceeds its total debt, and its interest payments are well covered by EBIT at 9.4 times coverage. Despite significant insider selling recently, Afentra trades at good value relative to peers and has not experienced meaningful shareholder dilution over the past year. Navigate through the intricacies of Afentra with our comprehensive balance sheet health report here. Gain insights into Afentra's outlook and expected performance with our report on the company's earnings estimates. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Avingtrans plc, with a market cap of £135.24 million, provides engineered components, systems, and services to the energy, medical, and infrastructure industries across various global regions including the UK, Europe, USA, Africa, Middle East, Americas, Caribbean, China and Asia Pacific. Operations: The company generates revenue through its Energy Advanced Engineering Systems segment, which accounts for £146.03 million, and its Medical and Industrial Imaging segment, contributing £4.41 million. Market Cap: £135.24M Avingtrans plc, with a market cap of £135.24 million, operates in the energy and medical sectors, generating significant revenue through its Energy Advanced Engineering Systems segment (£146.03 million). Despite a negative earnings growth of -33.8% over the past year, the company has achieved an average annual earnings growth of 14.7% over five years. Avingtrans maintains a satisfactory net debt to equity ratio of 4.5%, with short-term assets (£98M) exceeding both short-term (£57.6M) and long-term liabilities (£23.3M). Its interest payments are well covered by EBIT (5.7x), though profit margins have decreased to 2.7%. Unlock comprehensive insights into our analysis of Avingtrans stock in this financial health report. Understand Avingtrans' earnings outlook by examining our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Helios Underwriting plc, along with its subsidiaries, offers limited liability investment opportunities for shareholders in the Lloyd's insurance market in the UK and has a market cap of £172.74 million. Operations: Helios Underwriting plc does not report specific revenue segments. Market Cap: £172.74M Helios Underwriting plc, with a market cap of £172.74 million, has shown robust earnings growth of 236.7% over the past year, surpassing its five-year average of 59.2%. Despite a decline in revenue to £36 million and net income to £18.58 million for 2024, the company maintains high-quality earnings and strong financial health with short-term assets (£900M) covering both short-term (£858.2M) and long-term liabilities (£22.9M). Recent strategic changes include a share buyback program worth up to £2 million and executive appointments aimed at reducing underwriting risk and operational costs for future stability. Take a closer look at Helios Underwriting's potential here in our financial health report. Gain insights into Helios Underwriting's historical outcomes by reviewing our past performance report. Dive into all 407 of the UK Penny Stocks we have identified here. Looking For Alternative Opportunities? We've found 16 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:AET AIM:AVG and AIM:HUW. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Yahoo
Discover UK Penny Stocks To Watch In June 2025
The UK market has faced challenges recently, with the FTSE 100 index closing lower due to weak trade data from China, highlighting concerns about global economic recovery. Despite these broader market difficulties, certain investment opportunities remain attractive. Penny stocks, while often considered a relic of past trading days, still offer potential for growth when they are backed by strong financials and solid fundamentals. In this article, we explore several penny stocks that stand out as promising candidates for investors seeking hidden value in the UK market. Name Share Price Market Cap Financial Health Rating Foresight Group Holdings (LSE:FSG) £4.035 £453.9M ★★★★★★ Warpaint London (AIM:W7L) £4.70 £379.7M ★★★★★★ Cairn Homes (LSE:CRN) £1.876 £1.17B ★★★★★☆ Ultimate Products (LSE:ULTP) £0.756 £63.63M ★★★★★☆ Van Elle Holdings (AIM:VANL) £0.385 £41.66M ★★★★★★ Polar Capital Holdings (AIM:POLR) £4.525 £436.27M ★★★★★★ LSL Property Services (LSE:LSL) £2.99 £308.82M ★★★★★☆ Begbies Traynor Group (AIM:BEG) £1.095 £174.69M ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.86 £11.84M ★★★★★★ Braemar (LSE:BMS) £2.31 £72.24M ★★★★★★ Click here to see the full list of 407 stocks from our UK Penny Stocks screener. We'll examine a selection from our screener results. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Afentra plc is an upstream oil and gas company focused on operations in Africa, with a market cap of £107.65 million. Operations: The company's revenue is derived from its Oil & Gas - Exploration & Production segment, totaling $180.86 million. Market Cap: £107.65M Afentra plc, an upstream oil and gas company, has shown notable financial improvements with revenues reaching US$180.86 million for the year ending December 2024, a substantial increase from the previous year's US$26.39 million. The company transitioned to profitability with a net income of US$52.35 million compared to a prior net loss. Afentra's strong cash position exceeds its total debt, and its interest payments are well covered by EBIT at 9.4 times coverage. Despite significant insider selling recently, Afentra trades at good value relative to peers and has not experienced meaningful shareholder dilution over the past year. Navigate through the intricacies of Afentra with our comprehensive balance sheet health report here. Gain insights into Afentra's outlook and expected performance with our report on the company's earnings estimates. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Avingtrans plc, with a market cap of £135.24 million, provides engineered components, systems, and services to the energy, medical, and infrastructure industries across various global regions including the UK, Europe, USA, Africa, Middle East, Americas, Caribbean, China and Asia Pacific. Operations: The company generates revenue through its Energy Advanced Engineering Systems segment, which accounts for £146.03 million, and its Medical and Industrial Imaging segment, contributing £4.41 million. Market Cap: £135.24M Avingtrans plc, with a market cap of £135.24 million, operates in the energy and medical sectors, generating significant revenue through its Energy Advanced Engineering Systems segment (£146.03 million). Despite a negative earnings growth of -33.8% over the past year, the company has achieved an average annual earnings growth of 14.7% over five years. Avingtrans maintains a satisfactory net debt to equity ratio of 4.5%, with short-term assets (£98M) exceeding both short-term (£57.6M) and long-term liabilities (£23.3M). Its interest payments are well covered by EBIT (5.7x), though profit margins have decreased to 2.7%. Unlock comprehensive insights into our analysis of Avingtrans stock in this financial health report. Understand Avingtrans' earnings outlook by examining our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Helios Underwriting plc, along with its subsidiaries, offers limited liability investment opportunities for shareholders in the Lloyd's insurance market in the UK and has a market cap of £172.74 million. Operations: Helios Underwriting plc does not report specific revenue segments. Market Cap: £172.74M Helios Underwriting plc, with a market cap of £172.74 million, has shown robust earnings growth of 236.7% over the past year, surpassing its five-year average of 59.2%. Despite a decline in revenue to £36 million and net income to £18.58 million for 2024, the company maintains high-quality earnings and strong financial health with short-term assets (£900M) covering both short-term (£858.2M) and long-term liabilities (£22.9M). Recent strategic changes include a share buyback program worth up to £2 million and executive appointments aimed at reducing underwriting risk and operational costs for future stability. Take a closer look at Helios Underwriting's potential here in our financial health report. Gain insights into Helios Underwriting's historical outcomes by reviewing our past performance report. Dive into all 407 of the UK Penny Stocks we have identified here. Looking For Alternative Opportunities? We've found 16 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:AET AIM:AVG and AIM:HUW. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
